Weekly Rounds: How Much Threat Is Monkeypox Really, Biosafety Measures, and more

Article

Take 5 minutes to catch up on Infection Control Today’s highlights for the week ending June 10.

Here are 5 highlights from ICT®’s wide-ranging coverage of the infection prevention and control world. Everything from interviews with known opinion leaders, to the news that infection preventionists and other health care professionals can use on their jobs.

Monkeypox: CDC Raises Travel Alert, But How Much Threat Is it Really?

With more confirmed cases in the United States, and the CDC raising the travel alert to Level 2, should individuals be concerned? ICT investigates.

read more

Testing Should Be Appropriate Not Excessive

Biosafety risks for patients with SARS-CoV-2 may be overlooked, and some control measures may bring about cross-contamination of the tests being done and cause biosafety accidents.

Pilot Survey on Environmental Hygiene Contains Startling Results

Over 50 health care facilities from 35 countries participated from both higher and lower income settings.

RSV Requires Global Prevention Strategy Across all Income Levels

Respiratory syncytial virus does have a vaccine; however, the cost limits the distribution to the highest income countries, and a more cost-effective preventative strategy is needed.

Did Stethoscope Hygiene Improve Before and After COVID-19?

Despite the emphasis on more improved infection prevention practices, stethoscope hygiene continually falls short, possibly leading to more health care-acquired infections.

Newsletter

Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.

Recent Videos
David J. Weber, MD, MPH, president of the Society for Healthcare Epidemiology of America
Brenna Doran PhD, MA, hospital epidemiology and infection prevention for the University of California, San Francisco, and a coach and consultant of infection prevention; Jessica Swain, MBA, MLT, director of infection prevention and control for Dartmouth Health in Lebanon, New Hampshire; and Shanina Knighton, associate professor at Case Western Reserve University School of Nursing and senior nurse scientist at MetroHealth System in Cleveland, Ohio
Brenna Doran PhD, MA, hospital epidemiology and infection prevention for the University of California, San Francisco, and a coach and consultant of infection prevention; Jessica Swain, MBA, MLT, director of infection prevention and control for Dartmouth Health in Lebanon, New Hampshire; and Shanina Knighton, associate professor at Case Western Reserve University School of Nursing and senior nurse scientist at MetroHealth System in Cleveland, Ohio
© 2025 MJH Life Sciences

All rights reserved.